• Monepantel tablets to be tested in Phase I healthy dog trial due to commence 19th February 2019
• Designed to provide information on tablet number, administration frequency, blood levels and verification of safety for the Phase II trials in pet owners’ dogs with naturally occurring cancers
• Successful Phase I trial design in dogs also to be used as a bridging study to support US FDA IND application for clinical trials in humans.
OK, let the games begin!!
Ann: PharmAust Signs Agreement for US Phase I Trials in Dogs, page-2
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $89.00M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.5¢ | 19.8¢ | $199.9K | 985.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 554456 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 58399 | 3 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |